Teva Pharmaceutical Industries SG&A Expense Quarterly:
1.302B for March 31, 2013Teva Pharmaceutical Industries Historical SG&A Expense Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 1.302B |
| Dec. 31, 2012 | 1.374B |
| Sept. 30, 2012 | 1.206B |
| June 30, 2012 | 1.297B |
| March 31, 2012 | 1.24B |
| Dec. 31, 2011 | 1.351B |
| Sept. 30, 2011 | 918.00M |
| June 30, 2011 | 1.088B |
| March 31, 2011 | 1.053B |
| Dec. 31, 2010 | 1.079B |
| Sept. 30, 2010 | 987.00M |
| June 30, 2010 | 833.00M |
| March 31, 2010 | 934.00M |
| Dec. 31, 2009 | 970.00M |
| Sept. 30, 2009 | 883.00M |
| June 30, 2009 | 846.00M |
| March 31, 2009 | 800.00M |
| Dec. 31, 2008 | 680.00M |
| Sept. 30, 2008 | 648.00M |
| June 30, 2008 | 669.00M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About SG&A Expense
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
Learn More
TEVA SG&A Expense Quarterly Benchmarks
| Companies | |
|---|---|
| Alexza Pharmaceuticals | 4.606M |
| Mylan | 351.37M |
| Akorn | 12.34M |
TEVA SG&A Expense Quarterly Rankings
| Overall |
97th percentile 166 of 7590 |
| Sector |
97th percentile 17 of 651 in Healthcare |
| Industry |
98th percentile 1 of 65 in Drug Manufacturers - Specialty & Generic |
TEVA SG&A Expense Quarterly Range, Past 5 Years
| Minimum | 648.00M | Sep 2008 |
| Maximum | 1.374B | Dec 2012 |
| Average | 1.008B |
